Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Asparkam

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Asparkam

EINECS N/A
CAS No. 14842-81-0 Density g/cm3
PSA 310.35000 LogP -5.28420
Solubility N/A Melting Point N/A
Formula C8H10MgN2O8•C4H7NO4•2H•K Boiling Point 264.1°Cat760mmHg
Molecular Weight 460.75 Flash Point 113.5°C
Transport Information N/A Appearance N/A
Safety Moderately toxic by intravenous route. When heated to decomposition it emits toxic fumes of NOx and K2O. Risk Codes N/A
Molecular Structure Molecular Structure of 14842-81-0 (Asparkam) Hazard Symbols N/A
Synonyms

L-Aspartic acid,compounds,monopotassium salt,mixt. with dihydrogen (T-4)-bis[L-aspartato(2-)-kN,kO1]magnesate- (2-);Spartase;Aspara;Trophicard;L-Asparkam;MAGNESIUM POTASSIUM-l-ASPARTATE;ASPARTAT;

 

Asparkam Chemical Properties

Molecular Structure of Asparkam (CAS NO.14842-81-0):

IUPAC Name:  magnesium; potassium; (2S)-2-amino-4-hydroxy-4-oxobutanoate; 2-amino-4-hydroxy-4-oxobutanoate
Empirical Formula: C12H18KMgN3O12 
Molecular Weight: 459.6875 
Flash Point: 113.5 °C 
Enthalpy of Vaporization: 55.26 kJ/mol 
Boiling Point: 264.1 °C at 760 mmHg 
Vapour Pressure: 0.00289 mmHg at 25°C 
Classification Code : Drug / Therapeutic Agent ; Nutrient
Synonyms of Asparkam (CAS NO.14842-81-0):  L-Aspartic acid, monopotassium salt, mixt. with dihydrogen (T-4)-bis(L-aspartato(2-)-N,O(sup 1)magnesate(2-) ; L-Aspartic acid, monopotassium salt, mixt. with dihydrogen (T-4)-bis(L-aspartato(2-)-kappaN,kappaO1)magnesate(2-) ; L-Asparkam ; Aspartic acid, L-, magnesium salt (2:1) tetrahydrate, mixture with potassium hydrogen L-aspartate hemihydrate ; Asparkam ; Aspara

Asparkam Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 817mg/kg (817mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
mouse LD50 oral > 10gm/kg (10000mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
mouse LD50 subcutaneous 4226mg/kg (4226mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
rat LD50 intraperitoneal > 2gm/kg (2000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967.
rat LD50 intravenous 619mg/kg (619mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
rat LD50 oral > 10gm/kg (10000mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
rat LD50 subcutaneous 6902mg/kg (6902mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.

Asparkam Consensus Reports

 Magnesium potassium aspartate (CAS NO.14842-81-0) was reported in NIIRDN Drugs in Japan (Ethical Drugs).

Asparkam Safety Profile

Moderately toxic by intravenous route. When heated to decomposition it emits toxic fumes of NOx and K2O.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14842-81-0